Literature DB >> 19017896

Diagnosis and outcome of early pleural space infection following lung transplantation.

Momen M Wahidi1, Daniel A Willner1, Laurie D Snyder1, Jeremy L Hardison1, Jessica Y Chia1, Scott M Palmer2.   

Abstract

BACKGROUND: Despite the frequent occurrence of pleural effusions in lung transplant recipients, little is known about early posttransplant pleural space infections. We sought to determine the predictors and clinical significance of pleural infection in this population.
METHODS: We analyzed 455 consecutive lung transplant recipients and identified patients who had undergone sampling of pleural fluid within 90 days posttransplant. A case-control analysis was performed to determine the characteristics that predict infection and the impact of infection on posttransplant survival.
RESULTS: Pleural effusions undergoing drainage occurred in 27% of recipients (124 of 455 recipients). Ninety-six percent of effusions were exudative. Pleural space infection occurred in 27% of patients (34 of 124 patients) with effusions. The incidence of infection did not differ significantly by native lung disease or type of transplant operation. Fungal pathogens accounted for > 60% of the infections; Candida albicans was the predominant organism found. Bacterial etiologies were present in 25% of cases. Infected pleural effusions had elevated lactate dehydrogenase levels (p = 0.036) and markedly increased neutrophil levels in the pleural space (p < 0.0001) compared to noninfected effusions. A pleural neutrophil percentage of > 21% provides a sensitivity of 70% and a specificity of 79% for correctly identifying an infection. Patients with pleural space infection had a diminished 1-year survival rate compared to those without infection (67% vs 87%, respectively; p = 0.002).
CONCLUSION: Pleural infection with fungal or bacterial pathogens commonly complicates lung transplantation, and an elevated neutrophil level in the pleural fluid is the most sensitive and specific indicator of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017896      PMCID: PMC3732033          DOI: 10.1378/chest.08-1339

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  Lung transplantation at Duke University Medical Center.

Authors:  C L Lau; S M Palmer; T A D'Amico; V F Tapson; R D Davis
Journal:  Clin Transpl       Date:  1998

2.  Fungal empyema thoracis: an emerging clinical entity.

Authors:  S C Ko; K Y Chen; P R Hsueh; K T Luh; P C Yang
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

3.  Empyema complicating successful lung transplantation.

Authors:  D R Nunley; W F Grgurich; R J Keenan; J H Dauber
Journal:  Chest       Date:  1999-05       Impact factor: 9.410

4.  Safety of aerosolized amphotericin B lipid complex in lung transplant recipients.

Authors:  S M Palmer; R H Drew; J D Whitehouse; V F Tapson; R D Davis; R R McConnell; S S Kanj; J R Perfect
Journal:  Transplantation       Date:  2001-08-15       Impact factor: 4.939

5.  A survey of anti-fungal management in lung transplantation.

Authors:  J Stephen Dummer; Nikoloz Lazariashvilli; Jean Barnes; Mathew Ninan; Aaron P Milstone
Journal:  J Heart Lung Transplant       Date:  2004-12       Impact factor: 10.247

6.  Pleural effusions in lung transplant recipients: image-guided small-bore catheter drainage.

Authors:  Edith M Marom; Scott M Palmer; Jeremy J Erasmus; James E Herndon; Chunfeng Zhang; H Page McAdams
Journal:  Radiology       Date:  2003-07       Impact factor: 11.105

7.  Gastroesophageal reflux disease in lung transplant recipients.

Authors:  Denis Hadjiliadis; R Duane Davis; Mark P Steele; Robert H Messier; Christine L Lau; Steve S Eubanks; Scott M Palmer
Journal:  Clin Transplant       Date:  2003-08       Impact factor: 2.863

8.  Late postoperative pleural effusion following lung transplantation: characteristics and clinical implications.

Authors:  David Shitrit; Gabriel Izbicki; Gershon Fink; Daniel Bendayan; Dan Aravot; Milton Saute; Mordechai R Kramer
Journal:  Eur J Cardiothorac Surg       Date:  2003-04       Impact factor: 4.191

9.  Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital.

Authors:  Nur Yapar; Ulker Uysal; Mine Yucesoy; Nedim Cakir; Ayse Yuce
Journal:  Mycoses       Date:  2006-03       Impact factor: 4.377

10.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

Authors:  Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

View more
  7 in total

1.  Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.

Authors:  Renátó Kovács; Qasem Saleh; Aliz Bozó; Zoltán Tóth; Rudolf Gesztelyi; Tamás Kardos; Gábor Kardos; István Takacs; László Majoros
Journal:  Mycopathologia       Date:  2017-07-11       Impact factor: 2.574

Review 2.  Infectious pleural effusion status and treatment progress.

Authors:  Wei Yang; Bo Zhang; Ze-Ming Zhang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 3.  Fungal Infections After Lung Transplantation.

Authors:  Cassie C Kennedy; Raymund R Razonable
Journal:  Clin Chest Med       Date:  2017-05-20       Impact factor: 2.878

4.  Pulmonary tuberculous and tuberculous pericardial tamponade post lung transplant.

Authors:  George Makdisi; Robert Hooker; Christiano Caldeira
Journal:  Ann Transl Med       Date:  2017-08

Review 5.  Invasive fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham; Kieren A Marr
Journal:  Future Microbiol       Date:  2012-05       Impact factor: 3.165

Review 6.  Infectious Complications Following Solid Organ Transplantation.

Authors:  Alexis Guenette; Shahid Husain
Journal:  Crit Care Clin       Date:  2019-01       Impact factor: 3.598

Review 7.  Bacterial infections in lung transplantation.

Authors:  Margaret McCort; Erica MacKenzie; Kenneth Pursell; David Pitrak
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 3.005

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.